Cargando…
Human iPSC banking: barriers and opportunities
The introduction of induced pluripotent stem cells (iPSCs) has opened up the potential for personalized cell therapies and ushered in new opportunities for regenerative medicine, disease modeling, iPSC-based drug discovery and toxicity assessment. Over the past 10 years, several initiatives have bee...
Autores principales: | Huang, Ching-Ying, Liu, Chun-Lin, Ting, Chien-Yu, Chiu, Yueh-Ting, Cheng, Yu-Che, Nicholson, Martin W., Hsieh, Patrick C. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819403/ https://www.ncbi.nlm.nih.gov/pubmed/31660969 http://dx.doi.org/10.1186/s12929-019-0578-x |
Ejemplares similares
-
Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy
por: Nicholson, Martin W., et al.
Publicado: (2022) -
Banking on iPSC- Is it Doable and is it Worthwhile
por: Solomon, Susan, et al.
Publicado: (2014) -
Copy number variant hotspots in Han Taiwanese population induced pluripotent stem cell lines - lessons from establishing the Taiwan human disease iPSC Consortium Bank
por: Huang, Ching-Ying, et al.
Publicado: (2020) -
Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D
por: Jamieson, John J., et al.
Publicado: (2019) -
iPSC-MSCs and islet allograft tolerance
por: Wang, Tong-Song, et al.
Publicado: (2015)